Guillemette, Shawna <br/><br/>
Resistance to therapy in BRCA2 mutant cells due to loss of the nucleosome remodeling factor CHD4.  [electronic resource] 

 -  Genes & development  Mar 2015 
 - 489-94 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1549-5477 
<br/><br/><label>Standard No.: </label>10.1101/gad.256214.114  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Autoantigens--genetics<br/>Cell Line, Tumor<br/>Cisplatin--therapeutic use<br/>Drug Resistance, Neoplasm--genetics<br/>Female<br/>Genes, BRCA2--physiology<br/>Humans<br/>Mi-2 Nucleosome Remodeling and Deacetylase Complex--genetics<br/>Mutation--genetics<br/>Ovarian Neoplasms--drug therapy